UP-2.126: Low Dose Metronomic Oral Combined Administration of Etoposide and Cyclophosphamide in Metastatic Hormone Refractory Prostate Cancer After Docetaxol or Mitoxantrone Chemotherapy: A Phase II Study in China

Urology ◽  
2009 ◽  
Vol 74 (4) ◽  
pp. S270
Author(s):  
Y. Shen ◽  
D. Ye ◽  
X. Yao ◽  
S. Zhang ◽  
B. Dai ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Study ◽  
Hormone Refractory Prostate Cancer ◽  
Combined Administration ◽  
Hormone Refractory

A PHASE II STUDY OF DOCETAXEL, ESTRAMUSTINE, AND LOW DOSE HYDROCORTISONE IN HORMONE REFRACTORY PROSTATE CANCER

1999 ◽  
pp. 296 ◽  
Author(s):  
Diane Savarese ◽  
Mary-Ellen Taplin ◽  
Bonnie Marchesani ◽  
Willi Kreis ◽  
Wallace Akerley ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Study ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

Phase II Study of Low-Dose Docetaxel/Estramustine in Elderly Patients or Patients Aged 18-74 Years with Hormone-Refractory Prostate Cancer

2006 ◽  
Vol 5 (3) ◽  
pp. 212-218 ◽  
Author(s):  
Sreeni Chittoor ◽  
William Berry ◽  
David Loesch ◽  
Keith Logie ◽  
John Fleagle ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Elderly Patients ◽  
Phase Ii ◽  
Low Dose ◽  
Phase Ii Study ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory

Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study

2007 ◽  
Vol 52 (4) ◽  
pp. 1020-1027 ◽  
Author(s):  
Giuseppe Di Lorenzo ◽  
Riccardo Autorino ◽  
Sisto Perdonà ◽  
Michele De Laurentiis ◽  
Massimo D'Armiento ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Zoledronic Acid ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Hormone Refractory Prostate Cancer ◽  
Line Treatment ◽  
First Line ◽  
Hormone Refractory ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document